Health ❯ Medicine

Neurology

Alzheimer's Disease Neurodegenerative Diseases Parkinson's Disease Neurological Disorders Epilepsy Dementia Brain Injuries Neurological Conditions Migraine Cognitive Health

Alzheimer’s Theory Shifts Focus to Microtubules as Amyloid Beta Crowds Out Tau

Researchers suggest protecting the cell’s transport system could be a more promising therapeutic direction than focusing solely on plaques.

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

Preliminary Study Links GLP-1 Drugs to Fewer ER Visits in Chronic Migraine

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds

Alzheimer’s Study Finds Memory “Replay” Persists but Loses Structure

Novartis Licenses SciNeuro’s Brain‑Shuttle Alzheimer’s Antibodies in Deal Worth Up to $1.7 Billion

Glial Cells Deliver Mitochondria to Neurons, Easing Pain in Mice

Tau Neutralizes HSV-1 in Human Neuron Cultures, Pointing to Antiviral Roots of Alzheimer’s Features

Sanofi Ends PPMS Bid After Tolebrutinib Fails Phase 3 as FDA Delays Review for nrSPMS

Praxis Relutrigine Study Halted Early for Efficacy as FDA Review Meeting Set

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

Novo Defends Semaglutide Alzheimer’s Strategy After Phase 3 Miss

New Review Positions Camelid Nanobodies as a Promising Path for Brain Therapies

Study Finds PU.1-Low, CD28-Positive Microglia Curb Alzheimer’s Damage

Computational Screen Identifies Thiorphan for Spinal Cord Injury With Strong Preclinical Gains

Engineered Nanoparticles Restore Blood–Brain Barrier and Clear Amyloid in Alzheimer’s Mice

Nanoparticles Restore Brain Barrier, Reverse Alzheimer’s Signs in Mice

Inhaled CBD Dampens Brain Inflammation in Alzheimer’s Mouse Model

DMT Stabilizes Blood–Brain Barrier, Reduces Inflammation in Preclinical Stroke Study

Lancet Series Calls for Health-System Overhaul to Deliver New Alzheimer’s Blood Tests and Antibody Drugs